Quince Therapeutics
QNCX
$0.92
Share price
-4.17%
Change (1 day)
-43.56%
Change (1 year)
Categories
Earnings for Quince Therapeutics (QNCX)
Earnings in 2023 (TTM): -$27.08 M
According to Quince Therapeutics's latest financial reports the company's current earnings (TTM) are -$27.08 M. In 2022 the company made an earning of -$51.24 M an increase over its 2021 earnings that were of -$90.32 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Quince Therapeutics from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$27.08 M | -47.15% |
| 2022 | -$51.24 M | -43.27% |
| 2021 | -$90.32 M | 17.53% |
| 2020 | -$76.85 M | 99.1% |
| 2019 | -$38.6 M | 235.08% |
| 2018 | -$11.52 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 309.13% | 🇺🇸 USA |